Novel analysis of clonal diversification in blood b cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis

被引:17
|
作者
Abraham, Roshini S.
Manske, Michelle K.
Zuckerman, Neta S.
Sohni, Abhishek
Edelman, Hanna
Shahaf, Gitit
Timm, Michael M.
Dispenzieri, Angela
Gertz, Morie A.
Mehr, Ramit
机构
[1] Mayo Clin & Mayo Fdn, Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Hematol Res Lab, Rochester, MN 55905 USA
[3] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel
[4] Univ Minnesota, Minneapolis, MN 55455 USA
[5] Mayo Clin & Mayo Fdn, Coll Med, Div Hematol, Rochester, MN 55905 USA
基金
以色列科学基金会;
关键词
human; B cells; cell differentiation; repertoire development; plasma cells; light chain amyloidosis; immunoglobulin light chain;
D O I
10.1007/s10875-006-9056-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunoglobulin light chain amyloidosis (AL) is characterized by a limited clonal expansion of plasma cells and amyloid formation. Here, we report restriction in the diversity of VL gene usage with a dominance of clonally related B cells in the peripheral blood (PB) isotype-specific repertoire of AL patients. A rigorous quantification of lineage trees reveals presence of intraclonal variations in the PB clones compared to the bone marrow ( BM) clones, which suggests a common precursor that is still subject to somatic mutation. When compared to normal BM and PB B cells, AL clones showed significant but incomplete impairment of antigenic selection, which could not be detected by conventional R and S mutation analysis. Therefore, graphical analysis of B cell lineage trees and mathematical quantification of tree properties provide novel insights into the process of B cell clonal evolution in AL.
引用
收藏
页码:69 / 87
页数:19
相关论文
共 50 条
  • [31] Quantitative analysis of clonal bone marrow CD19+ B cells: Use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis (vol 120, pg 106, 2006)
    Manske, Michelle K.
    Zuckerman, Neta S.
    Timm, Michael M.
    Maiden, Stephanie
    Edelman, Hanna
    Shahaf, Gitit
    Barak, Michal
    Dispenzieri, Angela
    Gertz, Morie A.
    Mehr, Ramit
    Abraham, Roshini S.
    [J]. CLINICAL IMMUNOLOGY, 2007, 122 (03) : 356 - 356
  • [32] The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation
    Dittus, Christopher
    Uwumugambi, Nsabimana
    Sun, Fangui
    Sloan, J. Mark
    Sanchorawala, Vaishali
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (09) : 1729 - 1732
  • [33] High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate
    Milani, Paolo
    Fazio, Francesca
    Basset, Marco
    Berno, Tamara
    Larocca, Alessandra
    Foli, Andrea
    Riva, Marcello
    Benigna, Francesca
    Oliva, Stefania
    Nuvolone, Mario
    Rodigari, Lara
    Petrucci, Maria Teresa
    Merlini, Giampaolo
    Palladini, Giovanni
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (08) : 900 - 905
  • [34] Heavy/Light Chain Quantification Identifies Clonal Plasma Cell Disease in Patients with AL Amyloidosis and Normal Serum Free Light Chain Ratio
    Prokaeva, Tatiana
    Spencer, Brian
    Sun, Fangui
    McConnell, Nathaniel
    O'hara, Richard M.
    Seldin, David C.
    Connors, Lawreen
    Sanchorawala, Vaishali
    [J]. BLOOD, 2015, 126 (23)
  • [35] Prevalence of plasma cell and lymphoproliferative disorders among blood relatives of patients with light chain amyloidosis
    Staron, Andrew
    Verma, Karina
    Sanchorawala, Vaishali
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (05) : 861 - 865
  • [36] Stem Cell Mobilization and Autologous Transplant for Immunoglobulin Light-Chain Amyloidosis
    Gertz, Morie A.
    Schonland, Stefan
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (06) : 1133 - +
  • [37] Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report
    Gertz, Morie A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji K.
    Dingli, David
    Ansell, Stephen M.
    Gastineau, Dennis A.
    Inwards, David J.
    Johnston, Patrick B.
    Litzow, Mark R.
    Micallef, Ivana N. M.
    Porrata, Luis F.
    Leung, Nelson
    Hogan, William J.
    Buadi, Francis K.
    [J]. LEUKEMIA & LYMPHOMA, 2010, 51 (12) : 2181 - 2187
  • [38] Simultaneous Clinical Presentation of Renal Cell Carcinoma and Immunoglobulin Light Chain Amyloidosis
    Prasad, Bhanu
    Tangedal, Kirsten
    Chibbar, Rajni
    McIsaac, Mark
    [J]. CUREUS, 2018, 10 (05):
  • [39] Role of immunoglobulin heavy and light chain gene rearrangement analysis in differentiating between benign and malignant bone marrow B-cell lymphoid aggregates
    Evans, Mark G.
    Brynes, Russell K.
    Crymes, Anthony
    Reid, Jack
    Haghighi, Nahideh
    Botros, Christopher
    Zhao, Xiaohui
    Rezk, Sherif A.
    [J]. HUMAN PATHOLOGY, 2022, 130 : 58 - 64
  • [40] Automated Analysis of Plasma Cell Percentage and Light Chain Clonality in Bone Marrow Biopsy Whole Slide Images
    Azimi, Vahid
    Ngoc Tran
    Chang, Young Hwan
    Thibualt, Guillaume
    Medvedova, Eva
    Turner, Kevin
    Christian, Robert
    Raess, Phil
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1437 - 1438